Nox Health Acquires Somryst from Pear Therapeutics
May 25, 2023
Nox Health, a global sleep health company based in Alpharetta, Georgia, has acquired Somryst—the FDA-cleared prescription digital therapeutic for chronic insomnia—purchased from Pear Therapeutics. The acquisition brings an outcomes-validated insomnia treatment into Nox's value-based sleep care programs to expand its clinical offerings for employers, health plans and health systems.
- Buyers
- Nox Health
- Targets
- Somryst
- Sellers
- Pear Therapeutics
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
ResMed Acquires Somnoware
July 5, 2023
Healthcare Services
ResMed has acquired privately held Somnoware, a U.S.-based provider of cloud-based sleep and respiratory care diagnostics software, to expand its upstream sleep management capabilities and better connect diagnosis workflows with ResMed's treatment ecosystem. ResMed plans to retain Somnoware staff, integrate the platform into its solution portfolio while keeping it open and device-agnostic, and did not disclose material financial terms.
-
Vestar Capital Partners Invests Growth Capital in Nox Health
November 30, 2022
Healthcare Services
Vestar Capital Partners has made a strategic growth investment in Nox Health to accelerate development of the company's sleep diagnostic technology and expand adoption of its value-based sleep management solutions among employers and health plans. Financial terms were not disclosed; the investment will support product and service development and broader market expansion.
-
Sunrise Acquires Dreem Health to Expand U.S. Sleep Care Presence
December 12, 2024
Healthcare Services
Belgium-based sleep diagnostics company Sunrise has acquired California-based virtual sleep clinic Dreem Health to accelerate its U.S. expansion and add telehealth diagnosis and treatment capabilities. By pairing Sunrise's at-home sleep testing technology with Dreem Health's licensed providers and insurer partnerships, Sunrise aims to scale nationwide access to sleep care.
-
Omada Health Acquires Physera
May 19, 2020
Healthcare Services
Omada Health has acquired Physera, a digital musculoskeletal (MSK) care provider, to add virtual physical therapy and MSK management to Omada’s suite of digital chronic-care programs. Omada raised growth capital from Perceptive Advisors to finance the acquisition and accelerate integration of Physera’s telehealth and digital exercise therapy capabilities into its offerings for employers, health plans, and consumers.
-
Tempur Sealy (Somnigroup) Acquires Mattress Firm
May 9, 2023
Retail
Tempur Sealy International, Inc. signed a definitive agreement to acquire Mattress Firm, the U.S.'s largest mattress specialty retailer, in a transaction first announced at an approximate $4.0 billion enterprise value and completed in February 2025 with a reported total purchase price of roughly $5.0 billion. The deal was funded with approximately $2.7 billion of cash and the issuance of 34.2 million Tempur Sealy shares; following closing Tempur Sealy renamed itself Somnigroup International and will operate Mattress Firm as a decentralized business unit while divesting a portion of retail locations and the Sleep Outfitters business to MW SO Holdings (Mattress Warehouse).
-
Alkermes plc Acquires Avadel Pharmaceuticals plc
February 12, 2026
Pharmaceuticals
Alkermes plc completed its all-cash acquisition of Avadel Pharmaceuticals plc under an Irish High Court‑sanctioned scheme of arrangement, adding Avadel's FDA‑approved product LUMRYZ to Alkermes' commercial portfolio. The deal accelerates Alkermes' entry into the sleep medicine market, is expected to be accretive in 2026, and includes Avadel's clinical candidate valiloxybate.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.